文献速递衰弱、肌少症与跌倒老年慢病共病管理

Braden评分能否预测住院心力衰竭患者的结局?

Can Braden Score Predict Outcomes for Hospitalized Heart Failure Patients?
PubMed 文献 · J Am Geriatr Soc · 2017-02-21

该回顾性队列研究纳入642例以心力衰竭为主要诊断的住院患者,探讨Braden评分对30天死亡率、再入院率、住院时长和出院去向的预测效用。调整人口学和临床变量后,较高的出院Braden评分与较低的30天死亡率及更高的出院回家概率独立相关,较高的入院Braden评分与较短的住院时长独立相关,但Braden评分与30天再入院无显著关联。

要点

  • 出院Braden评分较高与30天死亡率降低独立相关(AOR 0.81,95%CI 0.66-0.996)。
  • 出院Braden评分较高与出院回家概率增加独立相关(AOR 1.66,95%CI 1.42-1.95)。

核心结论

  • Braden评分是心力衰竭住院患者死亡率、住院时长和出院去向的独立预测因素。
  • Braden评分与30天再入院无显著关联。
  • 有必要进一步探索使用Braden评分识别可能从专项干预中获益的住院患者。

研究设计与样本

  • 回顾性队列研究,纳入2012年1月1日至2013年6月30日期间某学术医疗中心642例以心力衰竭为主要诊断(ICD-9 428)的住院患者。
  • 主要预测因素为Braden评分,主要结局为30天死亡率,附加结局包括30天再入院、住院时长和出院去向。
  • 采用多变量方法调整患者人口学和临床变量后分析Braden评分与各结局的关联。

主要发现

  • 平均年龄61.8±16.2岁(范围19-101岁),30天死亡率为4.4%,30天再入院率为16.2%,平均住院时长为7.0±8.7天,78.2%出院回家。
  • 调整后,较高的出院Braden评分与30天死亡率降低显著相关(AOR 0.81,95%CI 0.66-0.996)。
  • 较高的出院Braden评分与出院回家显著相关(AOR 1.66,95%CI 1.42-1.95),Braden评分与30天再入院无显著关联。

临床怎么用

  • 对心力衰竭住院患者可常规关注Braden评分,低评分者可能提示死亡风险较高、住院时间较长及出院回家概率较低。
  • Braden评分可作为识别需要专项干预的心力衰竭住院患者的潜在工具,但其临床效用仍需进一步研究验证。

局限性

  • 本研究为单中心回顾性队列研究,结果外推需谨慎。
  • 原文未报告Braden评分预测结局的具体阈值或截断值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Braden score is a routine assessment of pressure ulcer risk hypothesized to identify the frail phenotype. OBJECTIVES: To investigate the predictive utility of the Braden score on outcomes of inpatients with heart failure (HF). DESIGN: Retrospective cohort study. SETTING: An academic medical center between January 1, 2012 and June 30, 2013. PARTICIPANTS: 642 inpatients with a primary diagnosis of HF (ICD-9 428). MEASUREMENTS: The primary predictor was Braden score. Primary outcome was 30-day mortality. Additional outcomes included 30-day readmission, length of stay (LOS), and discharge destination. Multivariable methods were used to determine the association between the primary predictor and each outcome adjusted for patient demographics and clinical variables. RESULTS: Mean admission and discharge Braden scores were 19.5 ± 2.3 (SD) (range = 9-23) and 20.0 ± 1.9 (range = 11-23), respectively (P < .0001). Mean age was 61.8 ± 16.2 years (range = 19-101). The 30-day mortality rate was 4.4%, 30-day readmission rate was 16.2%, mean LOS was 7.0 ± 8.7 days, and 78.2% were discharged home. After adjustment, higher (better) Braden score was significantly associated with decreased 30-day mortality (discharge Braden AOR 0.81 (95% CI 0.66-0.996)), and decreased average LOS (admission Braden β -0.52 days (P = .0002)). Higher discharge Braden score was significantly associated with discharge to home (AOR 1.66 (95% CI 1.42-1.95)). Braden score was not significantly associated with 30-day readmission. CONCLUSION: Braden score is an independent predictor of mortality, LOS, and discharge destination among inpatients with HF. Further exploration of the use of Braden scores to identify inpatients who might benefit from specialized intervention is warranted.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Bandle B, Ward K, Min SJ, et al. Can Braden Score Predict Outcomes for Hospitalized Heart Failure Patients? J Am Geriatr Soc. 2017. PMID: 28221672. doi:10.1111/jgs.14801

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。